Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Completed 2Withdrawn 1Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Postoperative Complications 1Multiple Endocrine Neoplasia Type 1 1

Interventions

Cyclophosphamide 1492Cisplatin 1414Paclitaxel 1317Radiotherapy 1261Carboplatin 1250Gemcitabine 1215Docetaxel 1109Bevacizumab 1030Fluorouracil 894Doxorubicin 792Dexamethasone 748Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 680Etoposide 678Irinotecan 634Filgrastim 621Cytarabine 586Leucovorin 579Nivolumab 558Vincristine 515Prednisone 475Cetuximab 465Bortezomib 459Erlotinib Hydrochloride 456Trastuzumab 447Methotrexate 438Lenalidomide 427Pemetrexed 420

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Interventional × Growth Hormone × Clear all
NCT03717168 2019-08-21

Effects of Growth Hormone on Difficult Ventilator Weaning Patients

National Cancer Institute, Egypt

Phase 2 Completed
60 enrolled

Postoperative Complications

NCT01853566 2014-09-03

Effects of Growth Hormone Administration on Muscle Strength and Body Composition in Men Over 50 Years Old

Universidade Federal do Rio de Janeiro

Phase 4 Completed
13 enrolled
Endocrine

Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡